Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Skin side effects of therapies for hematologic cancers
Phillips et al. J Am Acad Dermatol. 2018;78:1102-9.
Key clinical point: Dermatologic complications are more common in hematologic than solid tumor cancers and correlate with adverse outcomes.
Major finding: In cancer patients, dermatologic consults are associated with longer hospital stay (11 vs. 5 days) and death (9% vs. 2%).
Study details: Retrospective chart review of inpatient dermatology consultations during 2015.
Disclosures: The study was partly funded by the a grant from the National Cancer Institute’s Cancer Centers Program. Dr. Lacouture reported financial relationships with AstraZeneca, Adgero Biopharmaceuticals, Berg, Bristol-Myers Squibb, Foamix, Janssen, Legacy Healthcare, NovoCure, and Quintiles. Another author reported ties with Amgen, Roche, Eaisi, and P Value Communications.
Source: Phillips et al. J Am Acad Dermatol. 2018;78:1102-9.
Phillips et al. J Am Acad Dermatol. 2018;78:1102-9.